نتائج البحث - "Trilok V. Parekh"

1

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors

المؤلفون: Cinta Hierro, Alain C. Mita, Andrés Cervantes, Mark M. Awad, Josep Tabernero, Italo Poggesi, Rastilav Bahleda, Victor Moreno, Nancy Chan, Antoine Italiano, Ademi E. Santiago-Walker, Trilok V. Parekh, Emiliano Calvo, Jeffrey R. Infante, Alexander I. Spira, Ramaswamy Govindan, Bob Zhong, Martha Gonzalez, Hong Xie

المصدر: Clinical Cancer Research. 25:4888-4897

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Administration, Oral, Antineoplastic Agents, Drug resistance, Gastroenterology, Young Adult, 03 medical and health sciences, Hyperphosphatemia, 0302 clinical medicine, Refractory, Erdafitinib, Neoplasms, Quinoxalines, Internal medicine, medicine, Humans, Neoplasm, Dosing, Adverse effect, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Genetic Variation, Middle Aged, Prognosis, medicine.disease, Receptors, Fibroblast Growth Factor, Treatment Outcome, 030104 developmental biology, Oncology, Tolerability, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Retreatment, Pyrazoles, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfe6f93ed74fb1ed356ecce6401a4f2bTest
https://doi.org/10.1158/1078-0432.ccr-18-3334Test

2

Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

المصدر: Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3017eaed45ef2999509b405cfaf55672Test
http://europepmc.org/articles/PMC6771856Test

3

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

المؤلفون: Scott M. Schuetze, M. von Mehren, Shreyaskumar Patel, Martee L. Hensley, Mohammed M. Milhem, Sharon Anne McCarthy, Anthony D. Elias, B.A. Van Tine, Robert G. Maki, John T. Hamm, George Wang, Roland Elmar Knoblauch, Robin L. Jones, Trilok V. Parekh, George D. Demetri

المصدر: Annals of Oncology. 29:1995-2002

مصطلحات موضوعية: Adult, Leiomyosarcoma, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Time Factors, Adolescent, Dacarbazine, Subgroup analysis, Kaplan-Meier Estimate, Drug Administration Schedule, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, Progression-free survival, Antineoplastic Agents, Alkylating, Trabectedin, Aged, Aged, 80 and over, Performance status, business.industry, Hazard ratio, Age Factors, Original Articles, Liposarcoma, Hematology, Middle Aged, Progression-Free Survival, 030104 developmental biology, Tolerability, 030220 oncology & carcinogenesis, Administration, Intravenous, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726292b9056c2dd8855eb50a6ab1a4c5Test
https://doi.org/10.1093/annonc/mdy253Test

4

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial

المؤلفون: Bradley J. Monk, Robert G. Maki, Robin L. Jones, Trilok V. Parekh, Sharon Anne McCarthy, George Wang, Roland Elmar Knoblauch, Martee L. Hensley, Mohammed M. Milhem, Daniel A. Rushing, Kristen N. Ganjoo, Arthur P. Staddon, George D. Demetri, Shreyaskumar Patel, Margaret von Mehren

المصدر: Gynecologic Oncology. 146:531-537

مصطلحات موضوعية: Leiomyosarcoma, 0301 basic medicine, Oncology, medicine.medical_treatment, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Tetrahydroisoquinolines, Clinical endpoint, Anthracyclines, Treatment Failure, Trabectedin, Aged, 80 and over, Hazard ratio, Obstetrics and Gynecology, Alanine Transaminase, Anemia, Middle Aged, Dacarbazine, Survival Rate, 030220 oncology & carcinogenesis, Retreatment, Uterine Neoplasms, Female, medicine.drug, Adult, medicine.medical_specialty, Anthracycline, Subgroup analysis, Dioxoles, Article, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Aspartate Aminotransferases, Antineoplastic Agents, Alkylating, Aged, Chemotherapy, business.industry, Leukopenia, Thrombocytopenia, Surgery, 030104 developmental biology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1072e8a4f69dc55911db604b46a48aeTest
https://doi.org/10.1016/j.ygyno.2017.06.018Test

5

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma

المؤلفون: Robert Z. Orlowski, Ivan Spicka, Heather J. Sutherland, Jesús F. San-Miguel, Trilok V. Parekh, Andrew Spencer, Alexander Suvorov, Tadeusz Robak, Anna Dmoszynska, Andrew Cakana, Roman Hájek, Pieter Sonneveld, Joan Bladé, Arnon Nagler, Liang Xiu, Noemi Horvath

المصدر: Cancer. 122:2050-2056

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e162d73a2739916e8e4f12e166effdb3Test
https://doi.org/10.1002/cncr.30026Test

6

Association of detectable levels of circulating tumor DNA (ctDNA) with disease burden in prostate cancer (PC)

المؤلفون: Trilok V. Parekh, Shinta Cheng, Karen Urtishak, Deborah Ricci, Kim N. Chi, Michael Gormley, Matthew R. Smith, Jason S. Simon, Gerhardt Attard

المصدر: Journal of Clinical Oncology. 38:5562-5562

مصطلحات موضوعية: Cancer Research, Prostate cancer, Oncology, Somatic cell, business.industry, Circulating tumor DNA, Point mutation, Cancer research, Medicine, business, medicine.disease, Disease burden

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::781b0d7ea9898d55f5259294c46df7ebTest
https://doi.org/10.1200/jco.2020.38.15_suppl.5562Test

7

Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial

المؤلفون: Patricia LoRusso, Luc Dirix, Manon T. Huizing, Roland Elmar Knoblauch, Jordi Rodon, Margaret von Mehren, Spyros Triantos, Lorrin K. Yee, Emiliano Calvo, Trilok V. Parekh, Youn C. Park, George D. Demetri, Italo Poggesi, Francis Mark Senecal, Analia Azaro, Jan de Jong

المصدر: Investigational new drugs

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::610934428ae309e962fc387d42195abcTest
https://pubmed.ncbi.nlm.nih.gov/29177975Test

8

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study

المؤلفون: Bradley J. Monk, Trilok V. Parekh, Roland Elmar Knoblauch, P.S. Cheng, Weimin Li, A.S. Matos-Pita, Prafull Ghatage, Youn C. Park, Reyna Favis, Deborah Ricci, Andres Poveda, Henitz Erin Devay, Antonio Nieto

المصدر: Annals of Oncology. 26:914-920

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Phases of clinical research, Dioxoles, Disease-Free Survival, Polyethylene Glycols, Breast cancer, Tetrahydroisoquinolines, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Doxorubicin, Antineoplastic Agents, Alkylating, Trabectedin, Aged, Ovarian Neoplasms, Chemotherapy, Antibiotics, Antineoplastic, BRCA1 Protein, business.industry, BRCA mutation, Nuclear Proteins, Hematology, Middle Aged, Endonucleases, medicine.disease, DNA-Binding Proteins, Treatment Outcome, Pharmacogenetics, Mutation, Disease Progression, Female, lipids (amino acids, peptides, and proteins), Neoplasm Recurrence, Local, business, Ovarian cancer, Transcription Factors, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b2be917e4ce84e561495b43235ae1cTest
https://doi.org/10.1093/annonc/mdv071Test

9

Association of plasma DNA repair deficient (DRD) status with clinical outcome of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA) plus prednisone/dexamethasone (+P/D)

المؤلفون: Karen Urtishak, Bertrand F. Tombal, Gerhardt Attard, Michael Gormley, Marjolein Lahaye, Florence Lefresne, Trilok V. Parekh, Shibu Thomas, Dong Shen, Deborah Ricci, Axel S. Merseburger

المصدر: Journal of Clinical Oncology. 37:5066-5066

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e714b0636379d78a0763233d218ebd42Test
https://doi.org/10.1200/jco.2019.37.15_suppl.5066Test

10

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

المؤلفون: Shreyaskumar Patel, Hussein Tawbi, Robert G. Maki, Scott M. Schuetze, Kristen N. Ganjoo, Martee L. Hensley, Trilok V. Parekh, Youn C. Park, Anthony D. Elias, Arthur P. Staddon, Mohammed M. Milhem, George D. Demetri, Margaret von Mehren, Nushmia Z. Khokhar, Robin L. Jones, Alexander I. Spira, Roland Elmar Knoblauch, Andrew Dean, Brian A. Van Tine

مصطلحات موضوعية: Adult, Leiomyosarcoma, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, Metastatic Liposarcoma, Anthracycline, Dacarbazine, Dioxoles, Disease-Free Survival, Drug Administration Schedule, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Tetrahydroisoquinolines, Internal medicine, medicine, Clinical endpoint, Humans, Survival rate, Antineoplastic Agents, Alkylating, Trabectedin, Aged, Aged, 80 and over, business.industry, Hazard ratio, Sarcoma, Liposarcoma, ORIGINAL REPORTS, Middle Aged, Surgery, Survival Rate, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f308d5cc710e09ee81456f72b714076aTest
https://europepmc.org/articles/PMC5070559Test/

تنقيح النتائج